Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AB Science S.A. stock logo
ABSCF
AB Science
$2.70
$3.21
$2.55
$3.84
N/AN/A39,925 shsN/A
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
$0.10
+12.7%
$0.10
$0.05
$0.30
N/AN/A417,595 shs198,985 shs
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
$0.02
+72.7%
$0.01
$0.00
$0.30
N/AN/A22,006 shs3,922 shs
1933 Industries Inc. stock logo
TGIFF
1933 Industries
$0.01
+2.7%
$0.01
$0.01
$0.02
N/AN/A74,342 shs57,300 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AB Science S.A. stock logo
ABSCF
AB Science
0.00%0.00%-2.33%-29.69%-70.00%
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
-3.80%-13.13%-10.32%-21.82%-46.58%
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
+132.73%+137.04%+12,700.00%+2.40%-95.94%
1933 Industries Inc. stock logo
TGIFF
1933 Industries
-9.60%-24.67%-13.08%+32.94%-20.98%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/AN/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/AN/AN/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/A0.00N/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/A0.00N/AN/AN/AN/A5/13/2024 (Estimated)
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/A0.00N/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/A0.00N/AN/AN/AN/A7/2/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AB Science S.A. stock logo
ABSCF
AB Science
89N/AN/ANot Optionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
641N/AN/ANot Optionable
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
3N/AN/ANot Optionable
1933 Industries Inc. stock logo
TGIFF
1933 Industries
87N/AN/ANot Optionable

MYCOF, TGIFF, FFNTF, ABSCF, and ATT Headlines

SourceHeadline
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
finance.yahoo.com - April 8 at 7:13 AM
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
accesswire.com - April 8 at 7:00 AM
1933 Industries Inc.1933 Industries Inc.
barrons.com - April 2 at 3:42 PM
1933 Industries Reports Q2 2024 Financials1933 Industries Reports Q2 2024 Financials
finance.yahoo.com - April 2 at 10:41 AM
1933 Industries Inc.: 1933 Industries Pauses CBD Manufacturing Division1933 Industries Inc.: 1933 Industries Pauses CBD Manufacturing Division
finanznachrichten.de - March 12 at 1:05 PM
1933 Industries Pauses CBD Manufacturing Division1933 Industries Pauses CBD Manufacturing Division
accesswire.com - March 12 at 9:30 AM
1933 Industries Issues Correction1933 Industries Issues Correction
accesswire.com - March 1 at 6:00 PM
1933 Industries Inc.: 1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures1933 Industries Inc.: 1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures
finanznachrichten.de - March 1 at 7:43 AM
1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures
accesswire.com - February 29 at 11:00 AM
Hitler takes political control 1933-1934 - CCEAHitler takes political control 1933-1934 - CCEA
bbc.co.uk - February 23 at 2:08 PM
Miller IndustriesMiller Industries
forbes.com - February 16 at 12:45 PM
1933 Industries Inc (TGIF)1933 Industries Inc (TGIF)
investing.com - February 8 at 8:12 PM
CLASSIC CLASSICS: 1933 Ford: V-8 Sedan was popular with the publicCLASSIC CLASSICS: 1933 Ford: V-8 Sedan was popular with the public
decaturdaily.com - January 21 at 12:21 PM
1933 Industries Stock (OTC:TGIFF) Earnings Dates and Earning Calls1933 Industries Stock (OTC:TGIFF) Earnings Dates and Earning Calls
benzinga.com - January 13 at 6:51 PM
1933 Industries reports Q1 results1933 Industries reports Q1 results
msn.com - January 2 at 5:37 PM
1933 Industries Inc.: 1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture1933 Industries Inc.: 1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture
finanznachrichten.de - January 2 at 12:31 PM
1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture
finance.yahoo.com - January 2 at 12:31 PM
1933 Industries reports Q4 results1933 Industries reports Q4 results
msn.com - November 29 at 9:05 AM
1933 Industries Reports Fourth Quarter and 2023 Year-End Financial Results and Posts Record Revenues of $18.3 Million1933 Industries Reports Fourth Quarter and 2023 Year-End Financial Results and Posts Record Revenues of $18.3 Million
finance.yahoo.com - November 29 at 12:41 AM
1933 Industries Stock (OTC:TGIFF) Dividends: History, Yield and Dates1933 Industries Stock (OTC:TGIFF) Dividends: History, Yield and Dates
benzinga.com - November 24 at 12:40 PM
1933 Industries Announces Approval of Debenture Amendments1933 Industries Announces Approval of Debenture Amendments
finance.yahoo.com - November 14 at 6:02 PM
1933 Industries Provides Corporate Update1933 Industries Provides Corporate Update
finance.yahoo.com - October 27 at 9:53 AM
Germany withdraws from League of Nations, disarmament pactGermany withdraws from League of Nations, disarmament pact
upi.com - October 15 at 11:24 PM
TGIFF - 1933 Industries Inc.TGIFF - 1933 Industries Inc.
finance.yahoo.com - September 11 at 6:25 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AB Science logo

AB Science

OTCMKTS:ABSCF
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

Abattis Bioceuticals

CNSX:ATT
Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
4Front Ventures logo

4Front Ventures

OTCMKTS:FFNTF
4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates in two segments, THC Cannabis and CBD Wellness. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment also sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. The CBD Wellness segment sells non-THC hemp derived products. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.
Mydecine Innovations Group logo

Mydecine Innovations Group

OTCMKTS:MYCOF
Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
1933 Industries logo

1933 Industries

OTCMKTS:TGIFF
1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.